New Peer-Reviewed Paper on MiCheck® Prostate

New Peer-Reviewed Paper on MiCheck® Prostate

Minomic is pleased to announce the publication of the company’s latest research paper supporting the utilisation of MiCheck® Prostate as an aid to diagnosing clinically significant prostate cancer. It is clear there is strong clinical need to identify those patients...
Minomic shared journey in the US market with 360Dx

Minomic shared journey in the US market with 360Dx

We had the opportunity to share Minomic’s journey from genesis of the company to launch of MiCheck® Prostate in the US market with 360Dx, a leading media outlet for the diagnostics industry. CEO of Minomic, Dr Brad Walsh, highlighted the clinical utility of this...